Connacht Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,069
Closed -$359K 90
2021
Q4
$359K Buy
+4,069
New +$359K 0.35% 75